Literature DB >> 891020

Adverse reactions to nitrofurantoin in relation to cellular and humoral immune responses.

O Bäck, S Lidén, S Ahlstedt.   

Abstract

Eighteen patients showing hypersensitivity to nitrofurantoin with symptoms like sudden fever, malaise, cough, pleuritis, leucocytosis and sometimes eosinophilia were analysed for immune reactions, i.e. lymphocyte transformation and specific antibodies. In addition, thirty-three individuals treated with the drug but with no clinical signs of the described reactions were included as controls. The lymphocyte transformation test (LTT) was found positive in ten out of the eighteen sensitive patients while one to three out of fourteen tested control patients were positive, depending on test conditions. An incubation period of 4 days in culture medium supplemented with autologous serum gave stimulation to a greater extent than did isologous serum and/or incubation for 6 days. The antibody determinations, with the enzyme-linked immunosorbent assay (ELISA), showed no IgE antibodies to nitrofurantoin in any of the patients. In contrast, most of the hypersensitive and even the control patients had specific IgG antibodies. The mean value of the antibodies of the sensitive group was higher than of the control group, but considerable overlapping between the groups was noted. In adverse reactions to nitrofurantoin a positive LTT and/or a high antibody titre to the drug favours an allergic mechanism and contributes to a more reliable diagnosis.

Entities:  

Mesh:

Substances:

Year:  1977        PMID: 891020      PMCID: PMC1541001     

Source DB:  PubMed          Journal:  Clin Exp Immunol        ISSN: 0009-9104            Impact factor:   4.330


  12 in total

1.  Letter: Nitrofurantoin-induced pulmonary fibrosis and lupus syndrome.

Authors:  O Bäck; R Lundgren; L G Wiman
Journal:  Lancet       Date:  1974-05-11       Impact factor: 79.321

2.  Enzyme-linked immunosorbent assay, Elisa. 3. Quantitation of specific antibodies by enzyme-labeled anti-immunoglobulin in antigen-coated tubes.

Authors:  E Engvall; P Perlmann
Journal:  J Immunol       Date:  1972-07       Impact factor: 5.422

3.  In vitro stimulation of murine spleen cells using a microculture system and a multiple automated sample harvester.

Authors:  D M Strong; A A Ahmed; G B Thurman; K W Sell
Journal:  J Immunol Methods       Date:  1973-04       Impact factor: 2.303

4.  Modulation of in vitro lymphocyte transformation by antibodies: enhancement by antigen-antibody complexes and inhibition by antibody excess.

Authors:  J J Oppenheim
Journal:  Cell Immunol       Date:  1972-03       Impact factor: 4.868

5.  The response of lymphocytes from tuberculin-positive or negative humans to various doses of PPD-tuberculin in vitro.

Authors:  B S Nilsson
Journal:  Cell Immunol       Date:  1972-03       Impact factor: 4.868

6.  Intensive hospital monitoring of adverse reactions to drugs.

Authors:  N Hurwitz; O L Wade
Journal:  Br Med J       Date:  1969-03-01

7.  Diagnosis of drug allergy in vitro with the lymphocyte transformation test.

Authors:  B Halpern; N Amache
Journal:  J Allergy       Date:  1967-09

8.  Immunoelectrophoretic 'tailing' of albumin line due to albumin-IgG antibody complexes: a side effect of nitrofurantoin treatment?

Authors:  A M Teppo; K Haltia; O Wager
Journal:  Scand J Immunol       Date:  1976       Impact factor: 3.487

9.  Lupus-like syndrome associated with pulmonary reaction to nitrofurantoin. Report of three cases.

Authors:  O Selroos; J Edgren
Journal:  Acta Med Scand       Date:  1975 Jan-Feb

10.  Nitrofurantoin lung sensitivity: report of a case with prolonged nitrofurantoin lymphocyte sensitivity and interaction of nitrofurantoin-stimulated lymphocytes with alveolar cells.

Authors:  H R Pearsall; J Ewalt; M S Tsoi; S Sumida; D Backus; R H Winterbauer; D R Webb; H Jones
Journal:  J Lab Clin Med       Date:  1974-05
View more
  4 in total

Review 1.  Drug allergy: an overview.

Authors:  R D DeSwarte
Journal:  Clin Rev Allergy       Date:  1986-05

2.  Systemic Inflammatory Response Syndrome Secondary to Nitrofurantoin.

Authors:  Molly R McGarry; Meredith W Wagner; Barry M Wall
Journal:  J Investig Med High Impact Case Rep       Date:  2021 Jan-Dec

3.  Systemic Inflammatory Response Syndrome from Nitrofurantoin: A Case Report.

Authors:  Ryan A O'Connor; Vaidahi Patel; Valerie Lang; Wunnie Brima
Journal:  Am J Case Rep       Date:  2022-03-16

4.  Identification of Novel Environmental Substances Relevant to Pediatric Graves' Disease.

Authors:  Qin Xia; Jingjing Liu; Xu Xu; Wei Gu; Kefeng Gu; Xiuli Chen; Rongrong Xie; Dandan Zhang; Haiying Wu; Hui Sun; Fengyun Wang; Linqi Chen; Ting Chen
Journal:  Front Endocrinol (Lausanne)       Date:  2021-06-23       Impact factor: 5.555

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.